Please wait

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13D/A 0001539497-25-001480 0000921669 XXXXXXXX LIVE 7 Common Stock, no par value 08/14/2025 false 0000885590 071734107 Bausch Health Companies Inc. 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 Jesse Lynn, Esq. (305) 422-4100 16690 Collins Avenue, Suite PH-1 Sunny Isles Beach FL 33160 0001322827 N Icahn Partners Master Fund LP WC N DE 0.00 0.00 0.00 0.00 0.00 N 0 PN 0001322825 N Icahn Offshore LP OO N DE 0.00 0.00 0.00 0.00 0.00 N 0 PN 0001313666 N Icahn Partners LP WC N DE 0.00 0.00 0.00 0.00 0.00 N 0 PN 0001322826 N Icahn Onshore LP OO N DE 0.00 0.00 0.00 0.00 0.00 N 0 PN 0001412093 N Icahn Capital LP OO N DE 0.00 0.00 0.00 0.00 0.00 N 0 PN 0001412091 N IPH GP LLC OO N DE 0.00 0.00 0.00 0.00 0.00 N 0 PN 0001034563 N Icahn Enterprises Holdings L.P. OO N DE 0.00 0.00 0.00 0.00 0.00 N 0 PN 0001257324 N Icahn Enterprises G.P. Inc. OO N DE 0.00 0.00 0.00 0.00 0.00 N 0 CO 0001080113 N Beckton Corp. OO N DE 0.00 0.00 0.00 0.00 0.00 N 0 CO 0000921669 N Carl C. Icahn OO N X1 0.00 0.00 0.00 0.00 0.00 N 0 IN Common Stock, no par value Bausch Health Companies Inc. 2150 ST. ELZEAR BLVD. WEST QUEBEC A8 H7L 4A8 This Amendment No. 7 further amends the Schedule 13D, as previously amended, filed with the Securities and Exchange Commission (the "SEC") on February 11, 2021, relating to the Reporting Persons' interests in the Shares of the Issuer (the "Schedule 13D"), to furnish the additional information set forth herein. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Schedule 13D. As a result of the transactions reported in this Schedule 13D, the Reporting Persons may be deemed to beneficially own 0 Shares. As a result of the transactions reported in this Schedule 13D, the Reporting Persons may be deemed to beneficially own 0 Shares. On August 14, 2025, Icahn Partners LP sold 20,297,523 Shares and Icahn Partners Master Fund LP sold 14,423,595 Shares, in each case at a price of $9.00 per share (including brokerage fees). As a result of the transactions reported in this Schedule 13D, the Reporting Persons ceased to be the beneficial owners of more than five percent of the Shares and are no longer subject to the reporting requirements of Rule 13d-1(a) of the Exchange Act. Icahn Partners Master Fund LP /s/ Jesse Lynn Jesse Lynn / Chief Operating Officer 08/15/2025 Icahn Offshore LP /s/ Jesse Lynn Jesse Lynn / Chief Operating Officer 08/15/2025 Icahn Partners LP /s/ Jesse Lynn Jesse Lynn / Chief Operating Officer 08/15/2025 Icahn Onshore LP /s/ Jesse Lynn Jesse Lynn / Chief Operating Officer 08/15/2025 Icahn Capital LP /s/ Jesse Lynn Jesse Lynn / Chief Operating Officer 08/15/2025 IPH GP LLC /s/ Ted Papapostolou Ted Papapostolou / Chief Financial Officer 08/15/2025 Icahn Enterprises Holdings L.P. /s/ Ted Papapostolou Ted Papapostolou / Chief Financial Officer 08/15/2025 Icahn Enterprises G.P. Inc. /s/ Ted Papapostolou Ted Papapostolou / Chief Financial Officer 08/15/2025 Beckton Corp. /s/ Ted Papapostolou Ted Papapostolou / Vice President 08/15/2025 Carl C. Icahn /s/ Carl C. Icahn Carl C. Icahn 08/15/2025